45 The Bristol shared care glaucoma study 47 suggested the non-cost-effectiveness of this model was due to re-referrals back to the hospital from the community-based clinics and closer follow-up intervals in community-based clinics.
The main reason for non-cost-effectiveness in this case is due to the higher overhead costs in the community-based clinic, which could only approximate costs of a hospital-based review by increasing the number of patients seen in the community-based clinic to 25 patients per day.
For this application aqueous electrolytes are preferred, which offer several important advantages compared to organic electrolytes i.e. non-flammability, cost effectiveness, as well as higher ionic conductivity, solubility and thermal capacity.
Conceptually, inappropriate prescribing encompasses a range of behaviours for healthcare providers, including errors in prescribing, over-prescribing, under-prescribing, cost effectiveness, non-adherence and alternative therapies [ 5].
Our findings therefore confirm that a trade-off exists between cost, effectiveness and non-health arguments, despite the potential for uncontrolled interactions between health and non-health arguments.
Non-parametric bootstrapping will be used to investigate joint uncertainty in costs and effects via cost effectiveness acceptability curves.
The non-restrictive DNA requirements and cost effectiveness of the STAMP method make it an approachable alternative to genome-wide bisulfite sequencing.
Results confirm that a trade-off exists between cost, effectiveness and non-health arguments when respondents prioritise health programs.
Advantages of untreated fresh frozen non-irradiated allografts are their cost effectiveness, supposed better biological quality and availability in a local bone bank.
A report commissioned by the Department of Health [ 14] emphasised a need for further research investigating the clinical and cost effectiveness of non-pharmacological methods.
24 Subsequently, we calculated the cost effectiveness of non-excluded interventions by estimating the incremental cost per QALY gain (incremental cost effectiveness ratio) associated with each intervention group, relative to the next best alternative.
